Substance P recognition by a subset of human T lymphocytes - PubMed (original) (raw)

PMID: 6207205
PMCID: PMC425324
DOI: 10.1172/JCI111567

Substance P recognition by a subset of human T lymphocytes

D G Payan et al. J Clin Invest. 1984 Oct.

Abstract

The interaction of substance P with human blood T-lymphocytes, which stimulates T-lymphocyte proliferation, was quantified by both flow cytometric and direct binding assays. Fluorescence-detection flow cytometry recorded the binding of dichlorotriazinylamino-fluorescein-labeled substance P to 21 +/- 10% (mean +/- SD, n = 6) and 35 +/- 8% (n = 2) of human blood T-lymphocytes before and after stimulation with 10 micrograms/ml of phytohemagglutinin, respectively. The suppressor-cytotoxic (leu 2a) and helper-inducer (leu 3a) subsets identified by phycoerythrin-labeled monoclonal antibodies contained substance P-reactive T-lymphocytes at respective mean frequencies of 10 and 18%. [3H]substance P bound rapidly and reversibly to a mean of 7035 +/- 2850 sites/T-lymphocyte, which exhibited a dissociation constant (KD) of 1.85 +/- 0.70 X 10(-7) M (mean +/- SD, n = 5). [D-Pro2,D-Phe7,D-Trp9]substance P inhibited the binding of dichlorotriazinylamino-fluorescein-labeled substance P and [3H]substance P to T-lymphocytes at concentrations that suppressed the proliferative response to substance P. Substance P, eledoisin, and substance K (alpha-neurokinin), which all share with substance P the carboxy-terminal substituent -Gly-Leu-Met-NH2, were more potent than substance P in inhibiting the binding of [3H]substance P to T-lymphocytes, suggesting the importance of this sequence in the interaction. Purified human blood B-lymphocytes, monocytes, polymorphonuclear leukocytes, and platelets, and cultured Hut 78 cutaneous lymphoma T-cells, Jurkat cells, Molt-4 lymphoblasts, and HL-60 and U-937 monocyte-like cells all showed only minimal specific binding of [3H]substance P. The recognition of substance P by T-lymphocytes provides one mechanism for selective modulation of immunity by sensory nerves.

PubMed Disclaimer

Cited by

Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.
Gallicchio M, Benetti E, Rosa AC, Fantozzi R. Gallicchio M, et al. Br J Pharmacol. 2009 Feb;156(3):486-96. doi: 10.1111/j.1476-5381.2008.00033.x. Epub 2009 Jan 16. Br J Pharmacol. 2009. PMID: 19154444 Free PMC article.
Functional and immunological responses of Jurkat lymphocytes transfected with the substance P receptor.
Sudduth-Klinger J, Schumann M, Gardner P, Payan DG. Sudduth-Klinger J, et al. Cell Mol Neurobiol. 1992 Oct;12(5):379-95. doi: 10.1007/BF00711540. Cell Mol Neurobiol. 1992. PMID: 1281754
SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D.
Huang WQ, Wang JG, Chen L, Wei HJ, Chen H. Huang WQ, et al. J Exp Clin Cancer Res. 2010 May 24;29(1):55. doi: 10.1186/1756-9966-29-55. J Exp Clin Cancer Res. 2010. PMID: 20497542 Free PMC article.
Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease.
Shanahan F, Anton P. Shanahan F, et al. Dig Dis Sci. 1988 Mar;33(3 Suppl):41S-49S. doi: 10.1007/BF01538130. Dig Dis Sci. 1988. PMID: 3278868 Review.
Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes.
Lambert N, Lescoulié PL, Yassine-Diab B, Enault G, Mazières B, De Préval C, Cantagrel A. Lambert N, et al. Clin Exp Immunol. 1998 Aug;113(2):269-75. doi: 10.1046/j.1365-2249.1998.00621.x. Clin Exp Immunol. 1998. PMID: 9717978 Free PMC article.

References

1. Science. 1975 Nov 28;190(4217):889-90 - PubMed
1. J Comp Neurol. 1978 Mar 1;178(1):129-56 - PubMed
1. Experientia. 1978 Jul 15;34(7):860-2 - PubMed
1. Neuroscience. 1978;3(10):945-76 - PubMed
1. J Immunol. 1979 Sep;123(3):1068-70 - PubMed

Substance P recognition by a subset of human T lymphocytes - PubMed (original) (raw)